companydata.dkcompanydata.dk

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS: Financial statements 2018

CVR: 33242840

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS (CVR 33242840) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 27,832,693 and a net result of DKK 1,376,133 compared with DKK 1,016,623 the year before. That is an increase of 7.7% compared with the year before. Equity in the 2018 report amounted to DKK 4,860,061. The solvency ratio was 47.4%. The company had 29 employees in the financial year.

Gross Profit
DKK 27,832,693
Profit/Loss
DKK 1,376,133
Equity
DKK 4,860,061
Total Assets
DKK 10,260,526
Employees
29

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-27.8M1.4M4.9M29
2017-25.8M1M3.5M32
2016-23.6M1.2M2.5M-
2015-9.6M459K1.3M-
2014-4.8M299K845K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Robert James Leftwich joins the board of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApSOct 4, 2018

As of October 4, 2018, Robert James Leftwich has joined the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.

Timothy Jon McClain leaves the board of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApSOct 4, 2018

As of October 4, 2018, Timothy Jon McClain has left the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS: The 2017 annual report is outMay 30, 2018

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2017. Gross profit came to DKK 25,838,522, and the net result was DKK 1,016,623.

About PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Thomas Noel O´Leary. The board consists of Thomas Noel O´Leary (chair), John Sheahan and Simon Peter Hollywood. The company is owned by ICON CLINICAL (UK) LIMITED. The company has 49 employees (2026). In 2025, the company reported a gross profit of DKK 61,634,124 and a net result of DKK 3,053,580 compared with DKK 3,554,282 the year before. Equity in the 2025 report amounted to DKK 23,945,884.

Source: annual report 2025, Danish Business Authority